Oxford Finance Closes Debt Facility with Pulmonx
Oxford Finance closed a $20 million term loan agreement with Pulmonx. Proceeds of the loan will be used to support the company’s U.S. clinical trial of its proprietary treatment of emphysema.
September 18, 2014
Oxford Finance | Pulmonx
ABF Journal